effects [qlco]
Oral [spco]
Transdermal [ftcn]
Hormonal [qlco]
Replacement [topp]
Prostacyclin [bacs, eico, phsu]
Thromboxane A>2< [eico]
Objective [inpr]
Mechanism [ftcn]
CARDIOVASCULAR [bdsy]
Protection [fndg]
Hormone replacement therapy [topp]
Oral [spco]
Transdermal [ftcn]
HRT [topp]
production [ocac]
Prostacyclin [bacs, eico, phsu]
Endogenous [ftcn]
Antagonist [ortf]
Thromboxane A>2< [eico]
Methods [inpr]
Oral [spco]
Estradiol [horm, phsu, strd]
2-D [spco]
mg% [qnco]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
mg/d [qnco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Mu [inpr]
g d [qnco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg/d [qnco]
Courses [tmco]
intervals [tmco]
N NOS [aapp, imft]
GIVEN [cnce]
postmenopausal [tmco]
Women [popg]
urinary [qlco]
Excretion [phsf]
Metabolites [bacs]
Prostacyclin [bacs, eico, phsu]
Alpha [inpr]
3 6 [fndg]
DINOR [orch, phsu]
Alpha [inpr]
Thromboxane A>2< [eico]
Thromboxane B2 [eico]
DINOR [orch, phsu]
Thromboxane B2 [eico]
Measured [qlco]
Radioimmunoassays [lbpr]
purification [ftcn]
Extraction [topp]
Chromatography, High Performance Liquid [lbpr]
Sixth [qnco]
treatment [ftcn]
Cycle [tmco]
Oral [spco]
Hormone replacement therapy [topp]
Stimulated [npop]
Excretion [phsf]
Thromboxane B2 [eico]
3 4 [fndg]
MMOLE [qnco]
Creatinine [bacs, orch]
Mean deviation [clna]
Standard [qlco]
P NOS [aapp, imft]
DINOR [orch, phsu]
Thromboxane B2 [eico]
MMOLE [qnco]
Creatinine [bacs, orch]
P NOS [aapp, imft]
LED [mnob]
Dominance [idcn]
Thromboxane A>2< [eico]
Prostanoids [bacs, eico, phsu]
Occurred [acty]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Conclusions [idcn]
effects [qlco]
Various [irda]
HRT [topp]
Prostanoids [bacs, eico, phsu]
Copyright [inpr]
